Urinary mRNA markers of epithelial–mesenchymal transition correlate with progression of diabetic nephropathy
- 8 August 2011
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 76 (5) , 657-664
Abstract
Summary: Objective Epithelial–mesenchymal transition (EMT) plays an important role in the pathogenesis and progression of diabetic nephropathy (DN). Quantification of messenger RNA (mRNA) expression in urinary sediment is emerging as a noninvasive method of screening DN‐associated biomarkers. The aim of our study was to examine whether urinary mRNA profile of EMT‐associated genes may provide valuable clinical insight into the different stages of DN.Design and methods Diabetic nephropathy patients (n = 44) and healthy controls (n = 12) were enrolled in this study. DN patients were divided into three groups according to the levels of estimated glomerular filtration rate (eGFR): Group A (eGFR > 60 ml/min per 1·73 m2, n = 27), Group B (45 < eGFR < 60 ml/min per 1·73 m2, n = 9), and Group C (eGFR < 45 ml/min per 1·73 m2, n = 8). Relative mRNA abundance of α‐smooth muscle actin (α‐SMA), fibronectin, FSP1 and matrix metalloproteinase‐9 (MMP‐9) were quantified, and correlations between target mRNAs and clinical parameters were examined.Results The urinary mRNA levels of α‐SMA, fibronectin and MMP‐9 were significantly higher in the DN group compared with controls (P < 0·05), and mRNA levels increased with DN progression. Urinary mRNA levels of all target genes positively correlated with both urinary albumin excretion (UAE) and blood urea nitrogen (BUN). Moreover, the expression of α‐SMA, fibronectin and MMP‐9 mRNA correlated with serum creatinine levels (r = 0·514, r = 0·53 and r = 0·469, all P < 0·001) and eGFR levels (r = −0·374, r = −0·392 and r = −0·487, all P < 0·01).Conclusions Quantification of EMT‐associated genes in urinary sediment may be a novel approach for searching new biomarkers of DN.Keywords
This publication has 34 references indexed in Scilit:
- Monocytes induce proximal tubular epithelial–mesenchymal transition through NF‐kappa B dependent upregulation of ICAM‐1Journal of Cellular Biochemistry, 2011
- New Insights into Epithelial-Mesenchymal Transition in Kidney FibrosisJournal of the American Society of Nephrology, 2010
- Endothelial-Myofibroblast Transition Contributes to the Early Development of Diabetic Renal Interstitial Fibrosis in Streptozotocin-Induced Diabetic MiceThe American Journal of Pathology, 2009
- Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transitionHuman Pathology, 2009
- Epithelial-Mesenchymal Transition as a Potential Explanation for Podocyte Depletion in Diabetic NephropathyAmerican Journal of Kidney Diseases, 2009
- The basics of epithelial-mesenchymal transitionJournal of Clinical Investigation, 2009
- Detailed Technical Analysis of Urine RNA-Based Tumor Diagnostics Reveals ETS2/Urokinase Plasminogen Activator to Be a Novel Marker for Bladder CancerClinical Chemistry, 2007
- Connective Tissue Growth Factor Plays an Important Role in Advanced Glycation End Product–Induced Tubular Epithelial-to-Mesenchymal TransitionJournal of the American Society of Nephrology, 2006
- Targets to retard the progression of diabetic nephropathyKidney International, 2005
- Dissection of Key Events in Tubular Epithelial to Myofibroblast Transition and Its Implications in Renal Interstitial FibrosisThe American Journal of Pathology, 2001